LM
INSIDER · INBX · Inhibrx Biosciences, Inc. · CHIEF EXECUTIVE OFFICER
Lappe Mark
Every open-market transaction filed under this name, Sep 8 to Oct 14.
Filings
16
16 buys · 0 sells
Bought
$4.5M
open market, at cost
Sold
—
includes scheduled sales
Buys since
−0.4%
avg move from buy price, 16 priced
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 14 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 100 | $85.76 | $9K | +11.1% |
| Oct 14 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 2,451 | $85.00 | $208K | +12.1% |
| Oct 14 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 2,449 | $84.07 | $206K | +13.4% |
| Oct 14 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 100 | $85.76 | $9K | +11.1% |
| Oct 14 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 2,470 | $85.00 | $210K | +12.1% |
| Oct 14 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 2,470 | $84.07 | $208K | +13.4% |
| Sep 28 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 3,000 | $101.70 | $305K | −6.3% |
| Sep 28 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 1,500 | $98.88 | $148K | −3.6% |
| Sep 25 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 2,176 | $99.60 | $217K | −4.3% |
| Sep 25 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 3,324 | $98.87 | $329K | −3.6% |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 9,681 | $112.28 | $1.1M | −15.1% |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 1,219 | $111.88 | $136K | −14.8% |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 500 | $108.23 | $54K | −12.0% |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 1,100 | $107.12 | $118K | −11.0% |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 6,605 | $100.64 | $665K | −5.3% |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 5,895 | $99.29 | $585K | −4.0% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.